Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Current clinical development of PI3K pathway inhibitors in glioblastoma.

Current clinical development of PI3K pathway inhibitors in glioblastoma. Neuro Oncol. 2012 Jul; 14(7):819-29.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.